Kymera Therapeutics saw the highest growth of 70% in patent filings in February and 299% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 53% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Kymera Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Kymera Therapeutics has been focused on protecting inventions in United States(US) with eight publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 27% filings and 80% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Argentina(AR) patent Office are among the top ten patent offices where Kymera Therapeutics is filings its patents. Among the top granted patent authorities, Kymera Therapeutics has 80% of its grants in United States(US) and 20% in Israel(IL).

F. Hoffmann-La Roche could be the strongest competitor for Kymera Therapeutics

Patents related to rare diseases lead Kymera Therapeutics's portfolio

Kymera Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q1 2024.

Non-hodgkin lymphoma related patents lead Kymera Therapeutics portfolio followed by lymphoma, and chronic lymphocytic leukemia (cll)

Kymera Therapeutics has highest number of patents in non-hodgkin lymphoma followed by lymphoma, chronic lymphocytic leukemia (cll), waldenstrom macroglobulinemia (lymphoplasmacytic lymphoma), and cutaneous t-cell lymphoma. For non-hodgkin lymphoma, nearly 2% of patents were filed and 3% of patents were granted in Q1 2024.

For comprehensive analysis of Kymera Therapeutics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.